Retatrutide is a multi-functional peptide drug that acts as an agonist of the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Individuals who developed serious gastrointestinal complications, diagnosed optic nerve injuries, or other severe side effects after taking GLP-1 receptor agonist medications may qualify to pursue legal action
By reducing body weight, improving insulin sensitivity, lowering inflammatory markers, and addressing metabolic dysfunction, they target the very factors that make Hashimoto's management so challenging
doi: 10.1111/dom.13603
The reconstitution math explained Understanding the math behind reconstitution removes all guesswork from the process
Many patients report significant changes in hunger levels, fullness cues, and even food preferences